Health News Roundup: U.S. FDA authorizes Novavax COVID vaccine for adults; Enfamil maker Reckitt flies baby formula to U.S. from Singapore and more

4 weeks ago 48

Following is a summary of current health news briefs.

Enfamil maker Reckitt flies baby formula to U.S. from Singapore

Enfamil maker Reckitt on Wednesday afternoon flew 65 tonnes of baby formula to Chicago from its plant in Singapore, aiming to end a months-long shortage in the United States by late summer, a senior executive said. Similac maker Abbott Laboratories in February recalled dozens of types of baby formula, taking the country's biggest industry player off the market and creating one of the biggest U.S. food shortages in recent American history.

U.S. FDA authorizes Novavax COVID vaccine for adults

The U.S. Food and Drug Administration authorized the use of Novavax Inc's COVID-19 vaccine on Wednesday, clearing the way for a shot whose more traditional technology has raised hopes of wider acceptance among vaccine skeptics. It is the fourth COVID vaccine to be authorized for use in adults in the United States.

Canada's Ontario to offer second COVID booster dose to all adults

Ontario, Canada's most populous province, said on Wednesday that it would offer a second COVID-19 vaccine booster dose to everyone aged 18 and older from Thursday. "As we continue to manage COVID-19 for the long term, we're expanding second booster doses and extending the availability of free rapid antigen tests to give people the tools they need to stay safe and to ensure Ontario stays open," Ontario's Health Minister Sylvia Jones said in a statement.

Explainer-What is the BA.5 variant and why does it seem to be reinfecting so many people with COVID-19?

BA.5, part of the

Read Entire Article